SCHEMBL22730802

SCHEMBL22730802

CCCNC1CCN(/C(=N/C(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)CC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 5/20 0.37
CYP2C9 P11712 1/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
TSHR P16473 1/20 0.37
EPHX1 P07099 2/20 0.36
CTSK P43235 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
NPY2R P49146 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MERTK Q12866 1/20 0.33
NAMPT P43490 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22986774 0.87 CTSK (0.35) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL15295730 0.87 CTSK (0.35) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL22946500 0.85 CTSK (0.37) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL16439228 0.84 CTSK (0.47) HSD11B1CYP2C9EPHX1CTSKCA1
SCHEMBL2082768 0.81 ALDH1A1 (0.36) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL2082769 0.81 ALDH1A1 (0.36) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL17574400 0.80 MEN1 (0.36) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL28403064 0.80 MEN1 (0.36) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL9073870 0.80 ALDH1A1 (0.36) HSD11B1CYP2C9ALDH1A1KMT2AMEN1
SCHEMBL7299678 0.80 ALDH1A1 (0.36) HSD11B1CYP2C9ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3744722-A1 ß-LACTAMASE INHIBITOR AND USE THEREOF Suzhou Sinovent Pharmaceuticals Co., Ltd. (CN) 2020-12-02 EP disclosed